New Cancer Drug Benefits Half Of Patients In Trial, With Limitations - Forbes | new - Google News | October 30, 2014 at 10:43AM
October 30, 2014 at 10:43AM | new - Google News
New Cancer Drug Benefits Half Of Patients In Trial, With Limitations - Forbes
new - Google News
New Cancer Drug Benefits Half Of Patients In Trial, With Limitations Forbes A new cancer drug benefited 51% of stage III and IV melanoma patients during a phase II trial, achieving complete response (total cancer disappearance) in 26% during the treatment period. That was all in just 16 weeks of treatment, suggesting this drug ... |
October 30, 2014 at 10:43AM | new - Google News
New Cancer Drug Benefits Half Of Patients In Trial, With Limitations - Forbes
new - Google News
Nenhum comentário:
Postar um comentário